Curofy
Hepatitis B vaccine immunogenic, safe in diabetes patients
The hepatitis B vaccine was immunogenic in adults with type 2 diabetes and had a safety profile similar to that of control subjects in a manufacturer-sponsored phase-IV trial published in Human Vaccines & Immunotherapeutics.
See this content immediately after install